Synlait
(ASX:SM1) has reported its net profit after tax (NPAT) rose to $38.2 million for the 2017 financial year, marking the company’s strongest performance yet.
In more good news for Synlait, its revenue strengthened over the 2017 financial year, and lifted 39 per cent on FY16 to $759 million.
Its earnings before interest and tax (EBIT) also increased over on the prior year, to $65.8 Million from $61.1 million.
The New Zealand based milk and nutrition company says it continues to deliver on its growth strategy with a particular focus on infant baby formula.
No dividends were declared by the group for FY17.
Shares in Synlait
(ASX:SM1) are trading up 5.44 per cent to $4.85
